Helicobacter pylori Infection Aggravates Diet-induced Insulin Resistance in Association With Gut Microbiota of Mice.
Helicobacter pylori Infection Aggravates Diet-induced Insulin Resistance in Association With Gut Microbiota of Mice.
复制标题
幽门螺杆菌感染加重饮食诱导的胰岛素抵抗与小鼠肠道菌群的关系
DOI:
10.1016/j.ebiom.2016.09.010
复制
发表时间:
2016-10
期刊:
影响因子:
11.1
通讯作者:
Lu, Nonghua
中科院分区:
文献类型:
--
作者:
He, Cong;Yang, Zhen;Cheng, Dandan;Xie, Chuan;Zhu, Yin;Ge, Zhongming;Luo, Zhijun;Lu, Nonghua
Emerging evidence suggests that Helicobacter pylori infection is associated with insulin resistance (IR) yet the underlying mechanisms are still obscure. The vital role of gut microbiota in triggering IR has been increasingly reported, however, no study has explored the correlation of gut microbiota and H. pylori-associated IR. Using H. pylori-infected mice model fed different diet structures, we demonstrated that H. pylori infection significantly aggravated high-fat diet (HFD)-induced metabolic disorders at the early stage, the extent of which was close to the effect of long-term HFD. Interestingly, we observed dynamic alterations in gut microbiota that were consistent with the changes in the metabolic phenotype induced by H. pylori and HFD. There may be an interaction among H. pylori, diet and gut microbiota, which dysregulates the host metabolic homeostasis, and treatment of H. pylori may be beneficial to the patients with impaired glucose tolerance in addition to diet control. H. pylori infection aggravates high-fat diet induced metabolic disorders at the early stage in C57BL/6 mice. H. pylori infection in high-fat diet induces dynamic alterations of gut microbiota consistent with the metabolic phynotype. H. pylori is one of the most common human bacterial pathogens which causes gastric disorders. Epidemiological studies show that its infection is associated with insulin resistance although the mechanism is obscure. Our study demonstrates that H. pylori infection significantly aggravates high-fat diet induced metabolic disorders at the early stage, accompanied by dramatic alterations of gut microbiota. Moreover, the changes of gut microbiota are consistent with the metabolic phynotype, indicating an interaction among H. pylori, diet and gut microbiota. Thus, the treatment of H. pylori may be beneficial to the patients with impaired glucose tolerance in addition to diet control.
登录
查看更多内容
DOI:
10.1038/ismej.2012.8
发表时间:
2012-08
期刊:
The ISME journal
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.4
作者:
Goh KL;Chan WK;Shiota S;Yamaoka Y
通讯作者:
Yamaoka Y
影响因子:
3.7
作者:
Kim KA;Gu W;Lee IA;Joh EH;Kim DH
通讯作者:
Kim DH
影响因子:
16.2
作者:
Jeon CY;Haan MN;Cheng C;Clayton ER;Mayeda ER;Miller JW;Aiello AE
通讯作者:
Aiello AE
影响因子:
3.7
作者:
Knigge A;Klöting N;Schön MR;Dietrich A;Fasshauer M;Gärtner D;Lohmann T;Dreßler M;Stumvoll M;Kovacs P;Blüher M
通讯作者:
Blüher M